Business registries · firm from USPTO records
CUBIST PHARMACEUTICALS LLC
- Place
- 2000 GALLOPING HILL ROAD, KENILWORTH, NJ
- Entity type
- Limited liability company
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 1 granted 2013-04-15 to 2015-09-22
- Trademarks
- 9, 2 live
- Record
- EXACT high confidence: identical full name and state
- State business registration
- CUBIST PHARMACEUTICALS LLC EXACT high confidence: identical full name and state
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 9358267 | High purity lipopeptides | 2016-06-07 | PVGPATDIS, file of 2026-04-10 |
| US 9193729 | Inhibiting transient receptor potential ion channel TRPA1 | 2015-11-24 | PVGPATDIS, file of 2026-04-10 |
| US 9138456 | Lipopeptide compositions and related methods | 2015-09-22 | PVGPATDIS, file of 2026-04-10 |
| US 9120796 | B-lactamase inhibitor picoline salt | 2015-09-01 | PVGPATDIS, file of 2026-04-10 |
| US 9120795 | Crystalline form of a β-lactamase inhibitor | 2015-09-01 | PVGPATDIS, file of 2026-04-10 |
| US 9108966 | Beta-lactamase inhibitors | 2015-08-18 | PVGPATDIS, file of 2026-04-10 |
| US 9006421 | Cephalosporin compositions and methods of manufacture | 2015-04-14 | PVGPATDIS, file of 2026-04-10 |
| US 8969570 | Beta-lactamase inhibitors | 2015-03-03 | PVGPATDIS, file of 2026-04-10 |
| US 8962844 | 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors | 2015-02-24 | PVGPATDIS, file of 2026-04-10 |
| US 8962843 | 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors | 2015-02-24 | PVGPATDIS, file of 2026-04-10 |
| US 8940897 | 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors | 2015-01-27 | PVGPATDIS, file of 2026-04-10 |
| US 8933233 | 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors | 2015-01-13 | PVGPATDIS, file of 2026-04-10 |
| US 8933232 | 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors | 2015-01-13 | PVGPATDIS, file of 2026-04-10 |
| US 8927724 | Isoxazole beta-lactamase inhibitors | 2015-01-06 | PVGPATDIS, file of 2026-04-10 |
| US 8916709 | 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors | 2014-12-23 | PVGPATDIS, file of 2026-04-10 |
| US 8906866 | Antibiotic compositions for the treatment of gram negative infections | 2014-12-09 | PVGPATDIS, file of 2026-04-10 |
| US 8853357 | High purity lipopeptides | 2014-10-07 | PVGPATDIS, file of 2026-04-10 |
| US 8846610 | Methods for preparing purified lipopeptides | 2014-09-30 | PVGPATDIS, file of 2026-04-10 |
| US 8835382 | Lipopeptide compositions and related methods | 2014-09-16 | PVGPATDIS, file of 2026-04-10 |
| US 8809314 | Cephalosporin compound | 2014-08-19 | PVGPATDIS, file of 2026-04-10 |
| US 8796224 | Methods for preparing purified lipopeptides | 2014-08-05 | PVGPATDIS, file of 2026-04-10 |
| US 8697638 | Methods for preparing purified lipopeptides | 2014-04-15 | PVGPATDIS, file of 2026-04-10 |
| US 8685957 | Tazobactam arginine compositions | 2014-04-01 | PVGPATDIS, file of 2026-04-10 |
| US 8604164 | High purity lipopeptides | 2013-12-10 | PVGPATDIS, file of 2026-04-10 |
| US 8507647 | Antibacterial agents for the treatment of gram positive infections | 2013-08-13 | PVGPATDIS, file of 2026-04-10 |
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| ACCESS ZERBAXA | 86452186 | 2014-11-12 | Registration cancelled | 036, 044 | TRCFECO2, file of 2024-03-27 |
| Z | 86420428 | 2014-10-10 | Registered and renewed | 005 | TRTDXFAP, file of 2026-01-28 |
| Z | 86420424 | 2014-10-10 | Registered and renewed | 005 | TRTDXFAP, file of 2026-01-28 |
| ZEUFECTA | 85904069 | 2013-04-15 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| TOLCOTAZ | 85904062 | 2013-04-15 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| ZOLBIACT | 85904055 | 2013-04-15 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| TOLATAZ | 85904048 | 2013-04-15 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| CEBACTYN | 85904037 | 2013-04-15 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| CEBACTO | 85904030 | 2013-04-15 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
Possible related entities
- CUBIST PHARMACEUTICALS, INC. FL business registration FUZZY same street address as a state registration
- KEY PHARMACEUTICALS PUERTO RICO, INC. FL business registration FUZZY same street address as a state registration
- SCHERING-PLOUGH K ONE CORPORATION FL business registration FUZZY same street address as a state registration
- SCHERING REALTY CORPORATION FL business registration FUZZY same street address as a state registration
- SCHERING TRANSAMERICA CORPORATION FL business registration FUZZY same street address as a state registration
- ILUM HEALTH SOLUTIONS, LLC firm from USPTO records, 10 trademarks FUZZY same street address (trademark filings)
- Key Pharmaceutical, Inc. firm from USPTO records, 1 trademarks FUZZY same street address (trademark filings)
- Schering Corporation firm from USPTO records, 214 patents, 431 trademarks FUZZY same street address (trademark filings)
- SCHERING CORPORATON firm from USPTO records, 1 trademarks FUZZY same street address (trademark filings)
- SCHERING-PLOUGH firm from USPTO records, 6 patents, 2 trademarks FUZZY same street address (trademark filings)
- Schering-Plough Home Again LLC firm from USPTO records, 9 trademarks FUZZY same street address (trademark filings)
- TRIUS THERAPEUTICS LLC firm from USPTO records, 1 trademarks FUZZY same street address (trademark filings)
Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.